1. Home
  2. STTK vs IMSR Comparison

STTK vs IMSR Comparison

Compare STTK & IMSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.18

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

IMSR

Terrestrial Energy Inc.

N/A

Current Price

$6.05

Market Cap

233.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
IMSR
Founded
2016
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
233.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
IMSR
Price
$6.18
$6.05
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
617.5K
1.1M
Earning Date
03-05-2026
05-10-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$5.77
52 Week High
$6.27
$16.38

Technical Indicators

Market Signals
Indicator
STTK
IMSR
Relative Strength Index (RSI) 73.59 37.58
Support Level $1.85 $5.98
Resistance Level N/A $7.59
Average True Range (ATR) 0.42 0.43
MACD 0.05 0.01
Stochastic Oscillator 93.80 18.29

Price Performance

Historical Comparison
STTK
IMSR

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About IMSR Terrestrial Energy Inc.

Terrestrial Energy Inc is an industry-leading technology company committed to delivering reliable, emission-free, and cost-competitive nuclear energy with a transformative advanced reactor, the Integral Molten Salt Reactor (IMSR). Its mission is to transform global energy markets by commercializing its IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility.

Share on Social Networks: